Sorrento Therapeutics Inc. (SRNE) Rose 5.52% or 0.4 To Price $7.65 On Wednesday

Sorrento Therapeutics Inc. (SRNE) rose 5.52% or 0.4 to $7.65. It is close to 1.58 million shares traded, which is 55.65% compare to the average total volume 2.85 million. The market cap of SRNE is $632.60 million. The year to date change is 55.91%. The 52 week price range is from $1.5 to $8.25. Price of SRNE have changed 0.00% during last week. It have changed 26.09% over last month, 190.00% over last 3 months, N/A and 29.46% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for SRNE is 4.93. It is -35.56% below current price. The 200-day Moving Averages for SRNE is 2.73. It is -64.31% below current price. The 52-week High is 8.25. It is 7.84% from the current price. The 52-week Low is 1.5. It is -80.39% from current price.

There are some statistics of SRNE. It is has market cap $632.60 million. The share outstanding is 82.69 million. The average volume is 2.85 million. The revenue is 135.47M. It has 212.24M cash and 126.92M in debt. The gross profit is 132.76M. The percent of top 15 Institution holding is 33.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of SRNE is -20.08%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of SRNE is -5.54%.


Share this post